ArticleAnnals of translational medicine2022
Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer.
Jan Stenvang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.